Out of three manufacturing sites of Whyte Group, two sites are dedicated for pharmaceutical products.
Shanghai Whyte Asia Pioneer Pharmaceuticals Limited
This facility set up in Shanghai, China with an investment of USD 30 million is a dedicated facility for manufacture of a range of oral cephalosporins. The plant is designed according to USFDA and EMA guidelines and is awaiting approval
of DMF for 7-ADCA from USFDA. This facility has been inspected and approved by several global pharmaceutical companies. The current range of products include 7-ADCA, 7-ACCA, Cephalexin, Cefadroxyl, Cephradine, Cefixime
Grosvenor Chemicals Limited
This facility located in Huddersfield in West Yorkshire in England is dedicated, among other products, for manufacture of a range of pharmaceutical intermediates. Besides, this facility is also used for contract manufacturing and custom synthesis for pharmaceutical intermediates. This facility is GMP compliant and is inspected and approved by several pharmaceutical innovator companies around the world.